To provide direct evidence that REV7 expression is induced by 5-FU and oxaliplatin, we treated the CRC wild type (WT) cells with 5-FU and oxaliplatin for 3 days and observed that REV7 expression was increased in a dose dependent manner (Fig. 2e–h). The gene discussed is MAD2L2; the disease is colorectal carcinoma.